Details of Disease

General Information of Disease (ID: DISBT2JS)

Disease Name Peritoneal cavity cancer
Disease Class 2C51: Peritoneal cancer
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISBT2JS: Peritoneal cavity cancer
ICD Code
ICD-11
ICD-11: 2C51.Z
Expand ICD-10
C48,C56,C57,D28
Expand ICD-9
140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,183.2,221.0

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 10 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AL3818 DM3WP0N Phase 3 NA [1]
Cediranib DMWO5ZR Phase 3 Small molecular drug [2]
Pelareorep DM4WCF9 Phase 3 NA [3]
Ovapuldencel-T DM9JKSD Phase 2 NA [1]
DPX-survivac cancer vaccine DMOVQS4 Phase 1/2 NA [1]
GL-ONC1 DMEXNZN Phase 1/2 Oncolytic virus therapy [1]
COTI-2 DM6K3JQ Phase 1 NA [1]
Navicixizumab DMZ2G69 Phase 1 NA [1]
Prolanta DMLKF3H Phase 1 NA [1]
PTC596 DMI24V7 Phase 1 NA [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
This Disease is Treated as An Indication in 2 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Cobacan DMT4WDB Investigative NA [4]
TPM-001 DM2E1R9 Investigative NA [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5664).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.